Short description: Automating the modification of patient cells in personalized medicine can significantly reduce the cost and increase the availability for precision treatments, such as for leukemia. The cultivation (costliest) part is ideal for automation.
Market potential: Huge market that is small relative to the potential due to mostly manual process. Automating could make personalized treatment available to the masses.
Desired result: A proof-of-concept to show the ability to replace manual work in the cultivating part.
Information on challenge owner: Large company (> 3,000 staff).
Market presence of challenge owner: Global presence.
Keywords: Robotics; Sensors; Electronics; Embedded system; Biomedical engineering